Brand-name vs compounded
Hers vs Start Willow: Brand-Name or Compounded? (2026)
Hers $149/mo vs Start Willow $299/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.8 and 7.3 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Anyone shortlisting Hers against Start Willow is choosing between two direct-pay GLP-1 programs that solve the same problem in materially different ways.
The dividing line is regulatory, not cosmetic: Hers works with product the FDA has reviewed and approved, while Start Willow runs on compounded medication prepared by a pharmacy rather than manufactured under an approved application. Everything else about the two — price, support, shipping — follows from that decision.
Rather than restate two feature lists, this compares the two on cost over time, medication access, price stability and the support each one includes. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Lowest 12-month cost
- Hers — $1,788 against $3,538 at Start Willow, on each provider's own best published pricing.
- FDA-approved medication
- Hers — FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — a finished product the FDA has reviewed, rather than a compounded preparation.
- Tirzepatide access
- Start Willow — The only one of the two that publishes a dual GIP/GLP-1 option.
- Longest public track record
- Start Willow — 6,385 patient reviews against 6,200.
Hers vs Start Willow at a glance
Two programs, side by side, on their own published terms — with the rows that differ doing the work.
| Hers | Start Willow | |
|---|---|---|
| Advertised price | Wegovy pill from $149/mo, injectable from $199/mo | From $249 the first month, then $299/mo |
| Rate after promotions | $149/mo | $299/mo |
| Pricing structure | Published rate per medication | Promotional first month, then standard rate |
| Medication | FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen | Compounded semaglutide and compounded tirzepatide |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| State coverage | Not published | Not published |
| How fast you start | Online intake with clinician review | Fully online, no in-person visits |
| Patient reviews | 6,200 | 6,385 |
| eRxDoctor score | 9.8/10 | 7.3/10 |
Cost over a full course of treatment
A first-month price is a customer-acquisition number. So the table works in the timeframe treatment actually happens in.
| Hers | Start Willow | |
|---|---|---|
| First month | $149 | $249 |
| Months 2 onward | $149/mo | $299/mo |
| 6-month total | $894 | $1,744 |
| 12-month total | $1,788 | $3,538 |
| Best published plan | No multi-month discount published | No multi-month discount published |
Hers finishes the year $1,750 cheaper. For some patients the support Start Willow bundles closes that gap; for a patient who only needs the prescription written, it does not.
Price escalation to plan for: Start Willow moves from $249 to $299, a 20% increase. Set a calendar reminder for the month it changes.
Brand-name product versus a pharmacy preparation
On Hers's side of the line sits FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — product manufactured under an approved application, with the batch-to-batch consistency that approval requires.
Start Willow works with compounded semaglutide and compounded tirzepatide. Compounding is what puts $299/mo within reach; it also means no approval application stands behind the specific product you receive.
The honest framing is a trade, not a ranking. Compounded access is what has put GLP-1 treatment within reach of people whose insurance will not cover it; approved product is what removes a category of uncertainty about what is in the vial. Both of those are real.
A closer look at Hers
Hers offers FDA-approved Wegovy® (brand-name semaglutide) with a personalized care team and ongoing dose check-ins, no compounded medications. Against Start Willow, that puts it in the position of the cheaper option.
The process is online intake with clinician review, then home delivery, no insurance required. On money, expect published rate per medication — published upfront.
Behind the prescription sits personalized care team with ongoing dose check-ins. Available medication: FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen.
Hers pros
- No insurance required
- Personalized care team with ongoing dose check-ins
- FDA-approved brand-name Wegovy®, not a compounded product
Hers cons
- Higher starting price than most compounded competitors
- No compounded/generic alternative offered
Set beside Start Willow, the thing to weigh: there is no compounded tier to fall back on if the brand-name price stops working for you.
How Start Willow works
Start Willow positions itself on a delivery guarantee of three days or less and no membership stacked on the medication price. From $249 per Month
You start with fully online, no in-person visits; medication arrives via delivery guaranteed in 3 days or less. The price behaves as promotional first month, then standard rate.
Ongoing care is direct-pay model that bypasses insurance pre-authorization, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Start Willow pros
- Delivery guaranteed in 3 days or less
- Direct-pay model bypasses insurance pre-authorization entirely
- No insurance needed and no membership fees
- Medications comparable to Ozempic and tirzepatide
Start Willow cons
- Compounded medication only, no branded Ozempic or Wegovy
- Ongoing $299/month is among the higher rates on this list
- Price rises from $249 first month to $299/month ongoing
Against Hers specifically, the trade you are making: at $299 ongoing it is among the most expensive compounded programs here.
Who should choose Hers, and who should choose Start Willow
Choose Hers if:
- you want an FDA-approved finished medication rather than a compounded preparation
- the monthly rate is the constraint — $149/mo against $299/mo
- the feature you would actually use: brand-name Wegovy at a price that usually buys compounded medication elsewhere
- the twelve-month total is what you are optimizing ($1,788 against $3,538)
Choose Start Willow if:
- delivery works the way you want it to: delivery guaranteed in 3 days or less
- the level of clinical contact suits you: direct-pay model that bypasses insurance pre-authorization
- you want to start on their timeline: fully online, no in-person visits
- you want tirzepatide available without changing provider later
The trade-offs, stated plainly
On price. $149/mo against $299/mo. Start Willow is asking you to pay for a delivery guarantee of three days or less and no membership stacked on the medication price; decide whether that is a line item you will use.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On medication. Hers covers FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen; Start Willow covers compounded semaglutide and compounded tirzepatide. Only Start Willow publishes a tirzepatide route, which matters if semaglutide underdelivers.
On clinical contact. The support models differ — personalized care team with ongoing dose check-ins against direct-pay model that bypasses insurance pre-authorization — and that difference is felt in week two, not week one.
The clinical evidence, separated from the marketing
Weight loss percentages quoted in telehealth marketing come from trials neither Hers nor Start Willow ran. Here is the source material, and what regulators say alongside it.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
None of that settles which of these two to use. It does mean the drug is doing the work, and you are choosing who supplies it and on what terms.
Hers vs Start Willow: common questions
What happens when Start Willow's promotional price ends?
The rate moves to $299/mo, a 20% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Do Hers or Start Willow take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, Hers or Start Willow?
Start Willow, with 6,385 against 6,200. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Are Hers and Start Willow legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Hers operates on published rate per medication with pricing published upfront, Start Willow on promotional first month, then standard rate, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Neither Hers nor Start Willow penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
Is Hers or Start Willow better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis Hers has the stronger case; after month three, cost should take over.
The verdict
On the numbers, Hers wins the year: $1,788 against $3,538. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where Start Willow justifies itself is a delivery guarantee of three days or less and no membership stacked on the medication price. Where it does not is anywhere the extra spend buys features you will never open.
Get the maintenance-dose price in writing from whichever one you pick. That single question prevents most of the regret in this category.
Keep comparing
- Hers vs MaximusBrand-name vs compounded
- Hers vs He & She MDBrand-name vs compounded
- Start Willow vs MaximusBudget vs premium
- Start Willow vs He & She MDCoaching-supported vs medication-only
- Ro.co vs Elevate HealthBrand-name vs compounded
- Ro.co vs TMatesBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Hers or Start Willow, and does not sell treatment. Read our ranking methodology.